Home›Stock Screener›Bharat Immunologicals›Shareholding Pattern

Bharat Immunologicals Shareholding Pattern

As of Mar 2024, Bharat Immunologicals (BIBCL) promoter holding 59.25%, FII 0.00%, DII 0.00%, public 39.47%, total shareholders 35,313. Review BIBCL earnings valuation to evaluate earnings-based valuation against sector peers.

Promoter Holding 59.25%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 39.47%
Total Shareholders 35,313
As of Mar 2024

BIBCL Recent Shareholding Changes — Promoter, FII & DII

Bharat Immunologicals promoter, FII and DII holding change from Dec 2023 to Mar 2024. Check BIBCL market capitalization to track the company's total market size over time.

Promoter Holding Change
Dec 2023 to Mar 2024
No Change
FII Holding Change
Dec 2023 to Mar 2024
No Change
DII Holding Change
Dec 2023 to Mar 2024
No Change
Public Holding Change
Dec 2023 to Mar 2024
+0.12%

Bharat Immunologicals Quarterly Shareholding Trend — Promoter, FII, DII & Public

BIBCL promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see BIBCL screener.

Promoter
FII
DII
Public
Government

BIBCL Shareholding Pattern Data — Quarterly History

Bharat Immunologicals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2024 59.25% 0.00% 0.00% 0.00% 39.47% 1.28% 100.00% 35,313
Dec 2023 59.25% 0.00% 0.00% 0.00% 39.35% 1.39% 99.99% 34,910
Sept 2023 59.25% 0.00% 0.00% 0.00% 39.30% 1.45% 100.00% 34,201
Jun 2023 59.25% 0.00% 0.00% 0.00% 39.13% 1.61% 99.99% 34,818
Mar 2023 59.25% 0.00% 0.00% 0.00% 38.97% 1.77% 99.99% 35,535
Dec 2022 59.25% 0.00% 0.00% 0.00% 38.86% 1.88% 99.99% 36,242
Sept 2022 59.25% 0.00% 0.00% 0.00% 39.11% 1.63% 99.99% 35,411
Jun 2022 59.25% 0.00% 0.00% 0.00% 39.15% 1.59% 99.99% 35,695
Mar 2022 59.25% 0.00% 0.00% 0.00% 38.77% 1.97% 99.99% 36,323
Dec 2021 59.25% 0.00% 0.00% 0.00% 39.58% 1.17% 100.00% 36,869
Sept 2021 59.25% 0.00% 0.00% 0.00% 38.51% 2.24% 100.00% 36,799
Jun 2021 59.25% 0.00% 0.00% 0.00% 37.50% 3.25% 100.00% 38,195
Mar 2021 59.25% 0.00% 0.00% 0.00% 37.32% 3.43% 100.00% 33,938
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2024 59.25% 0.00% 0.00% 0.00% 39.47% 1.28% 100.00% 35,313
Dec 2023 59.25% 0.00% 0.00% 0.00% 39.35% 1.39% 99.99% 34,910
Sept 2023 59.25% 0.00% 0.00% 0.00% 39.30% 1.45% 100.00% 34,201
Jun 2023 59.25% 0.00% 0.00% 0.00% 39.13% 1.61% 99.99% 34,818
Mar 2023 59.25% 0.00% 0.00% 0.00% 38.97% 1.77% 99.99% 35,535
Dec 2022 59.25% 0.00% 0.00% 0.00% 38.86% 1.88% 99.99% 36,242
Sept 2022 59.25% 0.00% 0.00% 0.00% 39.11% 1.63% 99.99% 35,411
Jun 2022 59.25% 0.00% 0.00% 0.00% 39.15% 1.59% 99.99% 35,695
Mar 2022 59.25% 0.00% 0.00% 0.00% 38.77% 1.97% 99.99% 36,323
Dec 2021 59.25% 0.00% 0.00% 0.00% 39.58% 1.17% 100.00% 36,869
Sept 2021 59.25% 0.00% 0.00% 0.00% 38.51% 2.24% 100.00% 36,799
Jun 2021 59.25% 0.00% 0.00% 0.00% 37.50% 3.25% 100.00% 38,195
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2024 59.25% 0.00% 0.00% 0.00% 39.47% 1.28% 100.00% 35,313
Dec 2023 59.25% 0.00% 0.00% 0.00% 39.35% 1.39% 99.99% 34,910
Dec 2022 59.25% 0.00% 0.00% 0.00% 38.86% 1.88% 99.99% 36,242
Dec 2021 59.25% 0.00% 0.00% 0.00% 39.58% 1.17% 100.00% 36,869